Experiences with
Investigational Treatment294 public posts
Info on Golexanolone
May 23, 2024MenuSECTIONS
Golexanolone Phase 2 Trial for PBC Begins With First Patient Randomizations
Avatar photoJuliana Campos, PhD | May 23, 2024
Umecrine Cognition has announced the randomization of the first 2 patients into the second part of its ongoing phase 1b/2 clinical study of golexanolone
Exciting!
Food and Drug Administration (FDA) for investigational treatment, seladelpar, for the management of primary biliary cholangitis, including pruritus in adults without cirrhosis or with compensated cirrhosis (Child Pugh A) who are inadequate responders or intolerant to ursodeoxycholic acid (UDCA).
š¬ Discussion Topic: Embracing innovative approaches in mental health care
[i]Improving mental health outcomes is crucial for fostering individual well-being and building healthier communities. Mental health influences every aspect of life, from personal relationships to work performance and overall quality of life. By prioritizing mental health support and interventions, we
Want to take advantage of all our features? Just log in!
or
CAR T-cell therapy IMPT-514 gets FDA fast track designation for lupus
Investigational treatment targets active, resistant lupus nephritis and SLE
The U.S.